AccScience Publishing / JCBP / Online First / DOI: 10.36922/jcbp.2758
Cite this article
59
Download
1008
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Allostatic overload in the medically ill patients: Results from an observational study

Giovanni Mansueto1,2 Sara Romanazzo1 Caterina Romaniello3 Serena Guiducci3 Sara Galimberti4 Fiammetta Cosci1,5*
Show Less
1 Department of Health Sciences, University of Florence, Florence, Italy
2 School of Applied Sciences, London South Bank University, London, United Kingdom
3 Division of Rheumatology, Scleroderma Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
4 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
5 Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands
Submitted: 16 January 2024 | Accepted: 7 March 2024 | Published: 26 March 2024
© 2024 by the Author (s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

The present study aimed at evaluating the prevalence of allostatic overload (AO) among subjects with different medical diseases and explore whether medically ill patients with or without AO differ for specific clinical features (i.e., co-occurring mental or psychosomatic disorders). An observational cross-sectional study was carried out. Outpatients with a diagnosis of blood cancer, systemic sclerosis, or migraine received a clinical assessment which included the Mini International Neuropsychiatric Interview or the Structured Clinical Interview for DSM-5 and the Diagnostic Criteria for Psychosomatic Research-Revised Semi-Structured Interview (DCPR-R SSI). Four hundred and thirty-nine outpatients were enrolled. Among them, 39 (8.9%) had a diagnosis of blood cancer, 200 (45.5%) had a diagnosis of systemic sclerosis, and 200 (45.5%) had a diagnosis of migraine. A total of 104 (23.7%) patients had a DCPR-R diagnosis of AO. Patients with a diagnosis of blood cancer, migraine, or systemic sclerosis did not differ for DCPR-R AO prevalence (P = 0.082). Based on multiple regression analysis, medically ill patients with DCPR-R AO were more likely to satisfy the diagnosis of DCPR-R illness denial (odds ratio [OR] = 2.99, 95% confidence interval [CI] = 1.04 – 8.58), conversion symptoms (OR = 5.32, 95% CI = 1.16 – 24.38), or demoralization (OR = 2.57, 95% CI = 1.08 – 6.11) and a DSM-5 diagnosis of major depressive episode/disorder (OR = 1.90, 95% CI = 1.03 – 3.50), if compared to those without DCPR-R AO. DCPR-R AO is a clinically useful transdiagnostic feature potentially associated with other psychosomatic syndromes and mental disorders that may contribute to the disease burden and the poor global health conditions of medically ill patients.

Keywords
Stress
Medical disease
Cancer
Migraine
Systemic sclerosis
Funding
None.
Conflict of interest
The authors declare they have no competing interests.
References
  1. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338(3):171-179. doi: 10.31887/DCNS.2006.8.4/bmcewen

 

  1. McEwen BS. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev. 2007;87(3):873-904. doi: 10.1152/physrev.00041.2006

 

  1. Fava GA, McEwen BS, Guidi J, Gostoli S, Offidani E, Sonino N. Clinical characterization of allostatic overload. Psychoneuroendocrinology. 2019;108:94-101. doi: 10.1016/j.psyneuen.2019.05.028

 

  1. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;3(1):2-15. doi: 10.1016/s0018-506x(02)00024-7

 

  1. McEwen BS. Epigenetic interactions and the brain-body communication. Psychother Psychosom. 2017;86(1):1-4. doi: 10.1159/000449150

 

  1. Sonino N, Fava GA, Lucente M, Guidi J. Allostatic load and endocrine disorders. Psychother Psychosom. 2023;92(3):162-169. doi: 10.1159/000530691

 

  1. McEwen BS. Biomarkers for assessing population and individual health and disease related to stress and adaptation. Metabolism. 2015;64(3):S2-S10. doi: 10.1016/j.metabol.2014.10.029

 

  1. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA. 2001;98(8):4770-4775. doi: 10.1073/pnas.081072698

 

  1. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N. Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom. 2010;79(5):280-284. doi: 10.1159/000318294

 

  1. Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86(1):13-30. doi: 10.1159/000448856

 

  1. Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: A systematic review. Psychother Psychosom. 2020;90(1):11-27. doi: 10.1159/000510696

 

  1. Fava GA, Guidi J. Management of depression in medical patients: The role of clinical evaluation. Psychother Psychosom. 2023;92(5):287-291. doi: 10.1159/000533954

 

  1. Guidi J, Lucente M, Piolanti A, Roncuzzi R, Rafanelli C, Sonino N. Allostatic overload in patients with essential hypertension. Psychoneuroendocrinology. 2020;113:104545. doi: 10.1016/j.psyneuen.2019.104545

 

  1. Guidi J, Offidani E, Rafanelli C, Roncuzzi R, Sonino N, Fava GA. The assessment of allostatic overload in patients with congestive heart failure by clinimetric criteria. Stress Health. 2016;32(1):63-69. doi: 10.1002/smi.2579

 

  1. Porcelli P, Laera D, Mastrangelo D, Di Masi A. Prevalence of allostatic overload syndrome in patients with chronic cardiovascular disease. Psychother Psychosom. 2012;81(6):375-377. doi: 10.1159/000341179

 

  1. Cosci F, Svicher A, Mansueto G, et al. Mental pain and pain-proneness in patients with migraine: Results from the PAINMIG cohort-study. CNS Spectr. 2021;26(5):491-500. doi: 10.1017/S1092852920001480

 

  1. Leombruni P, Zizzi F, Pavan S, Fusaro E, Miniotti M. Allostatic overload in patients with fibromyalgia: Preliminary findings. Psychother Psychosom. 2019;88(3):180-181. doi: 10.1159/000496229

 

  1. Piolanti A, Gostoli S, Gervasi J, Sonino N, Guidi J. A trial integrating different methods to assess psychosocial problems in primary care. Psychother Psychosom. 2019;88(1):30-36. doi: 10.1159/000496477

 

  1. Van Den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737-2747. doi: 10.1002/art.38098

 

  1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(1):9-160. doi: 10.1111/j.1468-2982.2003.00824.x

 

  1. International Headache Society. The International Classification of Headache Disorders. 3rd ed. Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202

 

  1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.) the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.

 

  1. First MB, Williams JBW, Karg RS, et al. Structured Clinical Interview for DSM-5 Disorders, Clinician Version (SCID-5-CV). Arlington, VA: American Psychiatric Association; 2106.

 

  1. Rossi A, Alberio R, Porta A, Sandri M, Tansella M, Amaddeo F. The reliability of the mini-international neuropsychiatric interview--Italian version. J Clin Psychopharmacol. 2004;24(5):561-563.

 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

 

  1. Glasofer DR, Brown AJ, Riegel M. Structured clinical interview for DSM-IV (SCID). In: Wade T, editor. Encyclopedia of Feeding and Eating Disorders. Singapore: Springer; 2015. p. 1-4.

 

  1. Shabani A, Masoumian S, Zamirinejad S, Hejri M, Pirmorad T, Yaghmaeezadeh H. Psychometric properties of structured clinical interview for DSM-5 disorders-clinician version (SCID-5-CV). Brain Behav. 2021;11(5):e01894. doi: 10.1002/brb3.1894

 

  1. Osorio FL, Loureiro SR, Hallak JEC, et al. Clinical validity and intrarater and test-retest reliability of the structured clinical interview for DSM-5-clinician version (SCID-5-CV). Psychiatry Clin Neurosci. 2019;73(12):754-760. doi: 10.1111/pcn.12931

 

  1. Guidi J, Piolanti A, Berrocal C, Gostoli S, Carrozzino D. Incremental validity of the diagnostic criteria for psychosomatic research-revised (DCPR-R) to clinical assessment in primary care. Psychiatry Res. 2020;291:113233. doi: 10.1016/j.psychres.2020.113233

 

  1. Field A. Discovering Statistics Using IBM SPSS Statistics. 5th ed. UK: Sage, University of Sussex; 2017.

 

  1. Cumming G. Understanding the New Statistics: Effect Sizes, Confidence Intervals, and Meta-Analysis. New York, NY: Routledge; 2009.

 

  1. Serdar CC, Cihan M, Yücel D, Serdar MA. Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021;31(1):010502. doi: 10.11613/BM.2021.010502

 

  1. Munro BH. Statistical Methods for Health Care Research. 5th ed. Philadelphia, PA: Lippincott Willimans and Willkins; 2005.

 

  1. Heijmans M, Rijken M, Foets M, De Ridder D, Schreurs K, Bensing, J. The stress of being chronically ill: From disease-specific to task-specific aspects. J Behav Med. 2004;27(3):255-271. doi: 10.1023/b: jobm.0000028498.16767.a2

 

  1. Horwitz RI, Singer BH, Seeman TE. Biology and lived experience in health and disease: A tribute to Bruce McEwen (1938-2020), a scientist without silos. Psychother Psychosom. 2020;90(1):5-10. doi: 10.1159/000512598

 

  1. Horwitz RI, Cullen MR. Biology is not destiny. Psychother Psychosom. 2023;92(4):205-207. doi: 10.1159/000533449

 

  1. Patierno C, Fava GA, Carrozzino D. Illness denial in medical disorders: A systematic review. Psychother Psychosom. 2023;92(4):211-226. doi: 10.1159/000531260

 

  1. Engel GL. Conversion symptoms. In: MacBryde CM, Blacklow RS, editors. Signs and Symptoms, Applied Pathological Physiology and Clinical Interpretation. Philadelphia, PA: Lippincott Williams and Wilkins; 1970. p. 650-668.

 

  1. Quadt L, Critchley HD, Garfinkel SN. The neurobiology of interoception in health and disease. Ann NY Acad Sci. 2018;1428(1):112-128. doi: 10.1111/nyas.13915

 

  1. Woźniewicz A, Cosci F. Clinical utility of demoralization: A systematic review of the literature. Clin Psychol Rev. 2023;99:102227. doi: 10.1016/j.cpr.2022.102227

 

  1. Horwitz RI, Singer BH, Hayes-Conroy A, et al. Biosocial pathogenesis. Psychother Psychosom. 2022;91(2):73-77. doi: 10.1159/000521567

 

  1. Rossi MF, Tumminello A, Marconi M, et al. Sex and gender differences in migraines: A narrative review. Neurol Sci. 2022;43(9):5729-5734. doi: 10.1007/s10072-022-06178-6

 

  1. Zhong L, Pope M, Shen Y, Hernandez JJ, Wu L. Prevalence and incidence of systemic sclerosis: A systematic review and meta-analysis. Int J Rheum Dis. 2019;22(12):2096-2107. doi: 10.1111/1756-185X.13716

 

  1. Fava GA, Patierno C, Sonino N, Cosci F. New assessment strategies in consultation-liaison psychiatry. Acta Psychiatr Scand. 2024.

 

  1. Beck AT. Cognitive Therapy and the Emotional Disorders. 1st ed. New York: Penguin; 1979.

 

  1. Fava GA. Well-being Therapy, Treatment Manual and Clinical Applications. 1st ed. Basel, CH: Karger; 2016. doi: 10.1159/isbn.978-3-318-05822
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Print ISSN: 3060-8562, Published by AccScience Publishing